HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration.

Abstract
A better knowledge of the molecular mechanisms that govern leukocyte trafficking is of major relevance for the clinics. Both normal and pathologic extravasation of lymphocytes are a fine-tuned spatio-temporal event of migratory path-finding likely regulated by molecular guidance cues underlying cell movements in other systems. We have recently reported that members of the Eph family of receptor tyrosine kinases, namely EphA2 and one of its ligands, ephrin-A4 (EFNA4) can mediate in the traffic of chronic lymphocytic leukemia (CLL) cells and presumably of normal B cells between the blood and the tissues. The importance of EphA2-EFNA4 interactions at the endothelium-lymphocyte interface during TEM could rely on their attractive/repulsive properties. In the present work, we expand on those results by including additional insights and new suggestions for future studies that discuss the relevance of these molecules in overall cell adhesion dynamic events.
AuthorsEva M Trinidad, Agustín G Zapata, Luis M Alonso-Colmenar
JournalCell adhesion & migration (Cell Adh Migr) 2010 Jul-Sep Vol. 4 Issue 3 Pg. 363-7 ISSN: 1933-6926 [Electronic] United States
PMID20400865 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ephrin-A4
  • Ephrins
  • Receptor, EphA2
  • Receptors, Eph Family
Topics
  • Animals
  • Ephrin-A4 (metabolism)
  • Ephrins (metabolism)
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (enzymology, pathology)
  • Lymph Nodes (enzymology, pathology)
  • Lymphocytes (cytology, metabolism)
  • Receptor, EphA2 (metabolism)
  • Receptors, Eph Family (metabolism)
  • Signal Transduction
  • Transendothelial and Transepithelial Migration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: